$ULBI
ULTRALIFE CORP

2018 Q3 Form 10-Q Financial Statement

#000143774918019214 Filed on November 01, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q4
Revenue $20.33M $21.05M
YoY Change 1.96% -2.7%
Cost Of Revenue $14.29M $14.79M
YoY Change 4.16% -0.19%
Gross Profit $6.041M $6.255M
YoY Change -2.89% -8.15%
Gross Profit Margin 29.71% 29.72%
Selling, General & Admin $3.442M $3.637M
YoY Change -7.32% 1.03%
% of Gross Profit 56.98% 58.15%
Research & Development $1.099M $1.355M
YoY Change -7.26% -7.19%
% of Gross Profit 18.19% 21.66%
Depreciation & Amortization $496.0K $497.0K
YoY Change -2.17% -19.84%
% of Gross Profit 8.21% 7.95%
Operating Expenses $4.541M $4.992M
YoY Change -7.31% -3.26%
Operating Profit $1.500M $1.263M
YoY Change 13.46% -23.45%
Interest Expense -$20.00K -$40.00K
YoY Change -50.0% -20.0%
% of Operating Profit -1.33% -3.17%
Other Income/Expense, Net $21.00K -$20.00K
YoY Change -362.5% -166.67%
Pretax Income $1.521M $1.205M
YoY Change 19.48% -26.07%
Income Tax $86.00K $104.0K
% Of Pretax Income 5.65% 8.63%
Net Earnings $1.408M $1.098M
YoY Change 28.7% -37.26%
Net Earnings / Revenue 6.93% 5.22%
Basic Earnings Per Share $0.09 $0.07
Diluted Earnings Per Share $0.09 $0.07
COMMON SHARES
Basic Shares Outstanding 15.95M 15.56K
Diluted Shares Outstanding 16.52M 15.97K

Balance Sheet

Concept 2018 Q3 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.30M $14.60M
YoY Change 36.24% 37.74%
Cash & Equivalents $25.01M $18.24M
Short-Term Investments
Other Short-Term Assets $2.900M $2.600M
YoY Change 61.11% 18.18%
Inventory $23.12M $26.33M
Prepaid Expenses
Receivables $14.53M $14.66M
Other Receivables $0.00 $0.00
Total Short-Term Assets $66.01M $61.92M
YoY Change 20.44% 25.29%
LONG-TERM ASSETS
Property, Plant & Equipment $8.792M $7.570M
YoY Change 12.24% -5.36%
Goodwill $20.20M $20.46M
YoY Change -0.11% 2.47%
Intangibles $7.167M
YoY Change -0.38%
Long-Term Investments
YoY Change
Other Assets $96.00K $125.0K
YoY Change -32.87% 73.61%
Total Long-Term Assets $35.79M $35.27M
YoY Change 0.93% -0.15%
TOTAL ASSETS
Total Short-Term Assets $66.01M $61.92M
Total Long-Term Assets $35.79M $35.27M
Total Assets $101.8M $97.19M
YoY Change 12.77% 14.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.260M $8.787M
YoY Change -5.06% 20.5%
Accrued Expenses $4.100M $5.700M
YoY Change 7.89% 46.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.36M $14.24M
YoY Change 4.13% 25.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $32.00K $31.00K
YoY Change 18.52% 72.22%
Total Long-Term Liabilities $32.00K $31.00K
YoY Change 18.52% 72.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.36M $14.24M
Total Long-Term Liabilities $32.00K $31.00K
Total Liabilities $16.30M $18.14M
YoY Change -6.94% 7.42%
SHAREHOLDERS EQUITY
Retained Earnings -$77.71M -$82.89M
YoY Change -11.49% -8.45%
Common Stock $1.996M $1.966M
YoY Change 1.99% 1.76%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.47M $18.47M
YoY Change
Treasury Stock Shares $4.020M $4.020M
Shareholders Equity $85.59M $79.20M
YoY Change
Total Liabilities & Shareholders Equity $101.8M $97.19M
YoY Change 12.77% 14.68%

Cashflow Statement

Concept 2018 Q3 2017 Q4
OPERATING ACTIVITIES
Net Income $1.408M $1.098M
YoY Change 28.7% -37.26%
Depreciation, Depletion And Amortization $496.0K $497.0K
YoY Change -2.17% -19.84%
Cash From Operating Activities $2.740M -$370.0K
YoY Change 112.4% -109.07%
INVESTING ACTIVITIES
Capital Expenditures -$830.0K -$130.0K
YoY Change 219.23% -43.48%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$830.0K -$130.0K
YoY Change 219.23% -55.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 750.0K 130.0K
YoY Change 200.0% -48.0%
NET CHANGE
Cash From Operating Activities 2.740M -370.0K
Cash From Investing Activities -830.0K -130.0K
Cash From Financing Activities 750.0K 130.0K
Net Change In Cash 2.660M -370.0K
YoY Change 107.81% -109.16%
FREE CASH FLOW
Cash From Operating Activities $2.740M -$370.0K
Capital Expenditures -$830.0K -$130.0K
Free Cash Flow $3.570M -$240.0K
YoY Change 130.32% -105.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2017Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
168000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60442000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
59141000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2473000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1611000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
182246000
CY2017Q4 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
0
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
17500
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
0
CY2018Q3 ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
-21
CY2017Q4 ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
58
ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
27
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180211000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
363000
CY2017Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
133000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
707000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
529000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
277000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
292000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
27000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
42000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2018Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1252502
CY2017Q4 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1481844
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1252502
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1066844
CY2018Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
17500
ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
200
ulbi Proceeds From Government Subsidies
ProceedsFromGovernmentSubsidies
397000
ulbi Proceeds From Government Subsidies
ProceedsFromGovernmentSubsidies
CY2018Q3 ulbi Revenue Total Percentage
RevenueTotalPercentage
CY2017Q4 ulbi Revenue Total Percentage
RevenueTotalPercentage
ulbi Revenue Total Percentage
RevenueTotalPercentage
ulbi Revenue Total Percentage
RevenueTotalPercentage
ulbi Standard And Extended Product Warranty Accrual Increase Decrease For Warranties Issued Recovered
StandardAndExtendedProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedRecovered
9000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7260000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8787000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14533000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14657000
CY2018Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
121000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
315000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
97000
CY2017Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
106000
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
502250
CY2017Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
569000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
502250
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
984000
CY2018Q3 us-gaap Assets
Assets
101796000
CY2017Q4 us-gaap Assets
Assets
97186000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
66005000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
61916000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5041000
CY2018Q3 us-gaap Cash
Cash
25013000
CY2017Q4 us-gaap Cash
Cash
18241000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25013000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18241000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25454000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18330000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10629000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14607000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7124000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3978000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19976388
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19670928
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15956677
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15651217
CY2018Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1998000
CY2017Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1966000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
972000
CY2017Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1538000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4323000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
14289000
CY2017Q4 us-gaap Cost Of Revenue
CostOfRevenue
14792000
us-gaap Cost Of Revenue
CostOfRevenue
46390000
us-gaap Cost Of Revenue
CostOfRevenue
43656000
CY2018Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
14000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
42000
CY2018Q3 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
64000
CY2017Q4 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
48000
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
153000
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
199000
CY2018Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4000
CY2017Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12000
CY2018Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18000
CY2017Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
38000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
54000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
117000
CY2018Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32000
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32000
CY2018Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3904000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3867000
CY2018Q3 us-gaap Depreciation
Depreciation
496000
CY2017Q4 us-gaap Depreciation
Depreciation
497000
us-gaap Depreciation
Depreciation
1476000
us-gaap Depreciation
Depreciation
1507000
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-167000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
172000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.04
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.088
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1641000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2413000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y36D
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
71000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
681000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9529000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9259000
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
-145000
CY2018Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16199000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16344000
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6670000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7085000
CY2018Q3 us-gaap Goodwill
Goodwill
20201000
CY2017Q4 us-gaap Goodwill
Goodwill
20458000
CY2016Q4 us-gaap Goodwill
Goodwill
19965000
CY2017Q4 us-gaap Goodwill
Goodwill
20381000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
416000
CY2017Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
77000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-257000
CY2018Q3 us-gaap Gross Profit
GrossProfit
6041000
CY2017Q4 us-gaap Gross Profit
GrossProfit
6255000
us-gaap Gross Profit
GrossProfit
19873000
us-gaap Gross Profit
GrossProfit
19366000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1521000
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1205000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5461000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4226000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5461000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4226000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
86000
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
104000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
219000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
370000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2876000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1506000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2412000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-54000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-117000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2947000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1221000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
338000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
582000
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
571829
CY2017Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
407668
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
548004
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
323217
CY2018Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
13000
CY2017Q4 us-gaap Interest And Debt Expense
InterestAndDebtExpense
38000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
67000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
147000
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7813000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9707000
CY2018Q3 us-gaap Inventory Net
InventoryNet
23118000
CY2017Q4 us-gaap Inventory Net
InventoryNet
26326000
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13448000
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14606000
CY2018Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1857000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2013000
CY2018Q3 us-gaap Liabilities
Liabilities
16300000
CY2017Q4 us-gaap Liabilities
Liabilities
18137000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101796000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97186000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12364000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14239000
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
3230000
CY2018Q3 us-gaap Minority Interest
MinorityInterest
-97000
CY2017Q4 us-gaap Minority Interest
MinorityInterest
-154000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1754000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1120000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1994000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-971000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7531000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3657000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1408000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
1098000
us-gaap Net Income Loss
NetIncomeLoss
5185000
us-gaap Net Income Loss
NetIncomeLoss
3848000
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
27000
CY2017Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
57000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
4541000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
4992000
us-gaap Operating Expenses
OperatingExpenses
14385000
us-gaap Operating Expenses
OperatingExpenses
14940000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1500000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1263000
us-gaap Operating Income Loss
OperatingIncomeLoss
5488000
us-gaap Operating Income Loss
OperatingIncomeLoss
4426000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
96000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
125000
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-436000
CY2017Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
440000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-862000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1193000
CY2018Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6670000
CY2017Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
7085000
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3342000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2871000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34000
CY2017Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-53000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1994000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
971000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1357000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2900000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2603000
CY2018Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
64000
CY2017Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
131000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1120000
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
149000
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
172000
CY2018Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
86000
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
180000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
54000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
58000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
66000
us-gaap Profit Loss
ProfitLoss
5242000
us-gaap Profit Loss
ProfitLoss
3856000
CY2018Q3 us-gaap Profit Loss
ProfitLoss
1435000
CY2017Q4 us-gaap Profit Loss
ProfitLoss
1101000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
69234000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66711000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8792000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7570000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1099000
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1355000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3417000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3678000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
441000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
89000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77709000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82894000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
20330000
CY2017Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21047000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
66263000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
63022000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
217500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.22
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3986000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1860211
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1754752
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.10
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.68
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3442000
CY2017Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3637000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10968000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11262000
us-gaap Share Based Compensation
ShareBasedCompensation
707000
us-gaap Share Based Compensation
ShareBasedCompensation
529000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.026
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1174378
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
17499
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
3193000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.66
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3791000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1650364
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
79049000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.54
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.61
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y248D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y182D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y131D
CY2018Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
5.75
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
305460
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
85593000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
79203000
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
85496000
CY2018Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4019711
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4019711
CY2018Q3 us-gaap Treasury Stock Value
TreasuryStockValue
18469000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
18469000
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
571
CY2017Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
407
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
548
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
323
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16523
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15971
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16407
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15818
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15952
CY2017Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15564
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15859
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15495

Files In Submission

Name View Source Status
0001437749-18-019214-index-headers.html Edgar Link pending
0001437749-18-019214-index.html Edgar Link pending
0001437749-18-019214.txt Edgar Link pending
0001437749-18-019214-xbrl.zip Edgar Link pending
ex_126758.htm Edgar Link pending
ex_126759.htm Edgar Link pending
ex_126760.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20180930.xml Edgar Link completed
ulbi-20180930.xsd Edgar Link pending
ulbi-20180930_cal.xml Edgar Link unprocessable
ulbi-20180930_def.xml Edgar Link unprocessable
ulbi-20180930_lab.xml Edgar Link unprocessable
ulbi-20180930_pre.xml Edgar Link unprocessable
ulbi20180930_10q.htm Edgar Link pending
ulbi20180930_10qimg001.jpg Edgar Link pending